• Explore /
  • Poster
  • / Phase I study of pazopanib (PAZ) in combination with PCI-24781 (PCI) in patients (pts) with metastatic solid tumors with new tumor proliferation imaging correlates in renal cell carcinoma (RCC) and sarcoma.

Phase I study of pazopanib (PAZ) in combination with PCI-24781 (PCI) in patients (pts) with metastatic solid tumors with new tumor proliferation imaging correlates in renal cell carcinoma (RCC) and sarcoma.

Abstract Poster

Authors

null

Thach-Giao Truong

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Thach-Giao Truong , Jennifer A. Grabowsky , Stephanie Chen , Roth Ea , Andrew H. Ko , Terence W. Friedlander , Emily K. Bergsland , Andrea Lynne Harzstark , Anne Reinert , Gordon Fung , Adil Daud , Pamela N. Munster

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics - Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics

Sub Track

Epigenetics

Clinical Trial Registration Number

NCT01543763

Citation

J Clin Oncol 31, 2013 (suppl; abstr TPS2623)

DOI

10.1200/jco.2013.31.15_suppl.tps2623

Abstract #

TPS2623

Poster Bd #

12C

Abstract Disclosures

Similar Posters

First Author: Rahul Raj Aggarwal

First Author: Rahul Raj Aggarwal

First Author: Rahul Raj Aggarwal

First Author: Erica S Tsang